DRD2 and schizophrenia: It is known that dopaminergic signalling in the CNS is both normally important for cognitive function [36, 37] and abnormally perturbed in schizophrenia [38]; and that dopamine D2 receptor antagonists are generally effective anti-psychotic drugs [39].